null
100% Quality Guarantee
PhD-Level Technical Support
Key Features

H8 Biosimilar (Anti-5T4) Antibody (HDBS0137)

SKU HDBS0137
Antibody Type Biosimilar Reference Antibody
Applications IHC
Applications FC
Applications Drug Development
Applications Pharmacokinetics
Disease Area Cancer
Protein 5T4
Reactivity Human
Host Species Humanized
Isotype IgG1
€431
Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheet

H8 (Anti-5T4) Biosimilar Antibody (HDBS0137)

The H8 Biosimilar Anti-5T4 Antibody is a recombinant monoclonal antibody designed for research involving 5T4, a cell surface antigen associated with tumor growth and metastasis. The antibody, developed using cutting-edge biosimilar technology, is highly specific and exhibits potent anti-tumor activity in preclinical studies.5T4 is a promising target for cancer therapy due to its overexpression in a wide range of solid tumors, making it a potential biomarker for diagnosis and targeted treatment.

The H8 Antibody binds specifically to the 5T4 antigen, blocking its function and inhibiting tumor cell proliferation and migration.This biosimilar antibody offers a novel approach to cancer therapy, with the potential to improve treatment outcomes and reduce side effects compared to traditional chemotherapy. Its unique mechanism of action and high specificity make it a valuable tool for studying tumor biology and developing personalized treatment strategies for cancer patients.

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose